I love Linkedin as a platform for physicians to debate various issues back and forth, especially in this emerging field of regenerative orthopedic care and interventional vs. surgical orthopedics. One of the things that came up this week is that while we invented and continue to publish on the ACL stem cell injection procedure that uses precise fluoroscopy placement of cells, some surgeons have been performing a bone marrow stem cell injection using arthroscopy. Is this taking too much risk if an injection can do the same thing? Let’s look at this issue in more detail.
What is Interventional Orthopedics?
Interventional orthopedics is using precise image-guided injections of things that can help repair tissue. To learn more about the differences between interventional and surgical orthopedics, see my video below:
Our ACL Stem Cell Injection Technique
We’ve been treating ACL tears with stem cells for longer than anyone else on earth and perfected the fluoro guided procedure. Regrettably, while mild tears can be injected with ultrasound imaging, more severe tears require fluoroscopy. See my video below on that topic:
We are able to show MRI evidence of healing and excellent long-term outcomes in select ACL tears that represent about 70% of the cases that get operated today. See the before and after MRI results compilation that I have put together below:
Arthroscopy vs. an Injection
Knee arthroscopy is when a surgeon uses a device that can see into the knee. This has become the standard way of treating knee issues that don’t respond to physical therapy. However, the research showing that most of these arthroscopic procedures work is usually lacking and we have copious research that oftentimes these surgeries are no better than placebo procedures.
The controversy on Linkedin was that since a surgeon doesn’t usually possess the skill set or fluoroscopy equipment to perform a precise and complex injection of an ACL, should he or she perform the injection procedure with arthroscopic surgery? The main issue is the difference in risk between an arthroscopic surgery versus a precise injection using a 25 gauge needle. Meaning, in this scenario, we are using either non-invasive fluoroscopy to “see” where the needle is injecting or a surgery to open a window to “see”.
You don’t have to be an expert to see that the procedure on the left (an ACL injection using fluoroscopy) is far less invasive than the procedure on the right (knee arthroscopy).
While it would seem that there is prima facie evidence that an injection is less invasive and should carry a much lower complication profile than knee surgery, my surgical colleagues on Linkedin were not convinced. So let’s start to dive into some research after a quick tour through surgical underreporting of complications.
My Experience with Surgical Under-Reporting of Complications
One of the problems with reviewing the literature for orthopedic surgical complications is under-reporting. Meaning, I have seen countless complications of knee arthroscopy and other orthopedic surgeries where the treating surgeon never recognized the issue. This has spanned the gamut from mild nuisance nerve injuries leaving the patient with no sensation in a small area to serious biomechanical calamities that caused life-changing disability. Hence, IMHO this is likely why in the below review, you will see a huge 800% spread the reported complications for knee arthroscopy.
What Does the Research Say About Knee Arthroscopy Complications?
The possible complications of arthroscopic knee surgery include infection, nerve injury, new biomechanical problems like instability, surgical failure, and serious blood clots. The problem with an infection acquired in a hospital, where knee surgery is often performed, versus an outpatient clinic where a knee ACL injection is performed, is that an infection acquired in a hospital is more likely to be an antibiotic-resistant strain that’s more difficult to treat (like MRSA). This was highlighted in many news reports a few years back about infection outbreaks tied to orthopedic surgical instruments.
Overall knee arthroscopy reported complication rates vary between 1-8% (1 in 100 to 1 in 12 surgeries). Yep, that review of many papers on arthroscopic complications really has that big a range in the reporting of complications. How is that possible? See above.
In one large Sweedish registry study, the rate was a little more than 1 in 100. However, this recent study reported a complication rate that was nearly 5 times higher (4.7%). On the other hand, another study found a dramatically lower serious infection rate at between 1 in 200 and 1 in 100 surgeries. Again, the reported rates are all over the place.
So what’s the real rate of knee arthroscopy complications? If we pick the middle number, likely 1 in 30 to one in 50 patients will have a serious complication. Now let’s look at the complication rates due to knee stem cell injections.
Knee Stem Cell Serious Injection Complication Rates
Regrettably, there isn’t yet a large number of big studies reporting complication rates on knee stem cell injection procedures, In fact, we’re the only group on earth at this point that has meticulously tracked these events over nearly a decade and then required a physician to adjudicate them. This effort produced the world’s largest peer-reviewed study on stem cell injection complications used to treat orthopedic conditions. Click on the thumbnail below to see that study:
The highest serious complication rate that was connected to any stem cell injection procedure was 0.43% (13 possibly related complications divided by 2994 procedures). This was for culture expanded stem cells, fat grafts, and bone marrow concentrate (BMC). The complication rate of the BMC cases was much lower at only 57% of the above number or 0.25%. Realize that even this number is likely inflated relative to the surgical cases above, as this was reported by patients and independently adjudicated as possibly or probably related whereas all of the surgical data above is reported by surgeons who felt their complications were probably related. Meaning our dataset includes complications that are likely unrelated and is likely overreporting and the surgical data is more likely to underreport.
While all of the data above was for all types of BMC injections, what’s the actual rate in the three ACL stem cell injection datasets that we have published, submitted for publication, or are part of an ongoing RCT? That would be zero to date. However, that patient number is only about 100 cases. Hence, it’s likely that the real complication rate is somewhere between the above number and zero.
The Other Intangibles Not Being Discussed
Last year and earlier this year we again played around with a smaller format arthroscope. I say again because we had done this several years ago in 2012. In all of those cases, we eventually couldn’t come up with a reason why this was needed to inject ACLs when we could already do it so well using a non-invasive imaging method like fluoroscopy. However, despite that choice, a scary revelation occurred when we realized what our surgical colleagues do when surgically treating the knee.
You see, when you stick an arthroscope in to look around, you can encounter fat pads near the patella and near the ACL. These can be “in the way”, so they are often resected with one of the arthroscopic tools to improve the view. However, we now know that these fat pads are critical reservoirs of stem cells for the joint. So the intangible here is that if in using arthroscopy you have to remove critical parts of the joint, the risk matrix for the procedure just went way up.
An ACL Injection with Stem Cells is Far Safer than a Knee Arthroscopic Injection
No matter how you look at, an injection with a 25 gauge needle where a non-invasive way to see the needle will always be safer than knee surgery used to see the needle. That’s not only based on easy to see evidence (like the comparison of what gets shoved in the knee above) but also based on the research we have available. I don’t expect that will change.
The upshot? This is one of the core tennants of interventional orthopedics as a new medical speciality, we can do it less invasively and cheaper than the surgeons and help patients avoid surgery. So should surgeons begin retraining? I think the science and the math argues that they should.